The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients: A Randomised Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- Qazvin University Of Medical Sciences
- Enrollment
- 405
- Locations
- 3
- Primary Endpoint
- changes in low-density lipoprotein (LDL)-cholesterol level
- Last Updated
- 9 years ago
Overview
Brief Summary
Stroke is a major cause of morbidity and mortality, especially in low and middle income countries including Iran. Patients with recent stroke or TIA are at high risk for new vascular events. Several evidence based strategies in secondary prevention of stroke are available but frequently underused. The study is aimed to evaluate an intervention to improve patients with Stroke.
Investigators
Amir H Pakpour
Associate Professor of health psychology
Qazvin University Of Medical Sciences
Eligibility Criteria
Inclusion Criteria
- •aged 65 years or older
- •able to give informed consent
Exclusion Criteria
- •recurrent stroke
- •a diagnosis of subarachnoid haemorrhage
- •significant impairments precluding participation - inability to give informed consent
- •another condition likely to impact their participation in the trial (e.g. life-threatening condition other than cardiovascular disease)
- •expected discharge to hospital/nursing home setting
Outcomes
Primary Outcomes
changes in low-density lipoprotein (LDL)-cholesterol level
Time Frame: changes from baseline, 6 Months, 12 months and 18 months follow-up
changes in Patient-reported Adherence Medication Adherence Rating Scale
Time Frame: changes from baseline, 6 Months, 12 months and 18 months follow-up
a self-report measure of adherence (Medication Adherence Report Scale \[MARS-5\]) will be used .
changes in blood pressure
Time Frame: changes from baseline, 6 Months, 12 months and 18 months follow-up
Secondary Outcomes
- Changes in Self-monitoring to medication adherence(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in Illness Perceptions(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in intention to medication adherence(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in Action Plan(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in Coping Plan(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in quality of life(changes from baseline, 6 Months, 12 months and 18 months follow-up)
- Changes in perceived behavioral control to medication adherence(changes from baseline, 6 Months, 12 months and 18 months follow-up)